Tata 1mg, PharmEasy Flu Shot Demand Triples

Demand for flu vaccines is nearly three times higher than the same period last year, according to Tata 1mg. The surge has led to supply constraints in several cities. This rush coincides with a more than six-fold increase in H1N1 cases this monsoon season compared to previous years.

Major online healthcare platforms are responding. Tata 1mg, Apollo Homecare, and PharmEasy have all rolled out at-home flu vaccination services. Users can book and receive flu shots from trained nurses at home.

Vaccine Demand and Supply

Manisha Mishra, vice-president and lead for specialty pharma at Tata 1mg, told The Economic Times that sales have more than doubled since July. Demand across all major cities is roughly three times higher than last year. "Both corporates and individuals are actively seeking flu shots," she said. Mishra attributed this to higher awareness among doctors and patients and elevated viral spread nationwide.

The demand is partly driven by a newly available vaccine. Mishra noted significant demand for the recently updated 2026-27 flu vaccine, which has just reached the market. This vaccine is updated per World Health Organization recommendations to cover new and evolving influenza strains. Experts say this is critical as flu viruses change every year.

Rising Testing and Diagnostic Challenges

There is also a sharp rise in demand for rapid molecular diagnostics. Testing requests are coming from metropolitan cities and increasingly from tier-2 and tier-3 locations.

Kuldeep Singh Sachdeva, president and chief medical officer at Molbio Diagnostics, said the company is seeing a gradual but clear rise in orders for influenza testing solutions. These cover influenza A, influenza B, and subtypes like H3. "This trend is not limited only to North India," Sachdeva said. "The demand is picking up across other parts of the country and across different levels of the healthcare ecosystem."

The challenge this monsoon is diagnostic. H1N1, dengue, typhoid, and seasonal flu present overlapping symptoms like fever, cough, body ache, and fatigue. Without a confirmed diagnosis, doctors make treatment decisions based on clinical suspicion alone. Sachdeva emphasized the value of quick testing. "When testing can be completed within the same consultation window, physicians can quickly determine the appropriate course of action, reduce patient anxiety and provide timely guidance," he said.

Expert Recommendations and Context

Health experts recommend annual flu vaccination, particularly for high-risk groups. Anurag Agrawal, dean of biosciences and health research at Ashoka University, advises vaccination. "The usual protection measures like masks in crowded spaces, respiratory hygiene, avoiding overcrowding, ventilation and washing hands will also help," he said.

Rajiv Bahl, director general of the India Council of Medical Research (ICMR), said there is no cause for panic. He stated that seasonal influenza is generally mild. However, certain individuals have a higher risk of complications. This group includes elderly people, young children, individuals with underlying medical conditions or co-morbidities, and people with compromised immunity.